Search
Artelo Biosciences Inc
ARTLAdd to Watchlist
1.110USD
+0.010+0.91%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
747.04KMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-02The current earnings forecast score of Artelo Biosciences Inc is 6.00, ranking 331 out of 387 in the Biotechnology & Medical Research industry. The average price target is 30.00, with a high of 30.00 and a low of 30.00.
Analyst Rating
Based on
1
analysts
Hold
Current Rating
30.000
Target Price
+471.43%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
562
Total
5
Median
6
Average
Company name
Ratings
Analysts
Artelo Biosciences Inc
ARTL
1
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
113
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Artelo Biosciences Inc's price target?
Analysts forecast that Artelo Biosciences Inc's price target is USD 30.00, with the highest forecast at USD 30.00 and the lowest forecast at USD 30.00.
What is the analyst rating for Artelo Biosciences Inc?
Based on the ratings of Artelo Biosciences Inc's stock from 1 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.